116 related articles for article (PubMed ID: 1910877)
1. Decrease in pulmonary artery pressure with slow release nifedipine in Saudi patients with primary pulmonary hypertension.
Ribeiro PA; Sivanandan V; Shaikh A; Chalak W; Zaman L; Duran CM
Rev Port Cardiol; 1991 May; 10(5):413-8. PubMed ID: 1910877
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
Wimmer M; Schlemmer M; Ebner F
Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of acute and chronic effects of nifedipine in patients with secondary pulmonary hypertension].
Dubiel JP; Nikodemowicz M; Zmudka K; Mazurek S; Królikowski T
Kardiol Pol; 1991; 34(5):279-86. PubMed ID: 1921110
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
[TBL] [Abstract][Full Text] [Related]
5. Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months.
Musante R; Di Donato M
G Ital Cardiol; 1985 Nov; 15(11):1110-2. PubMed ID: 3830769
[TBL] [Abstract][Full Text] [Related]
6. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
Johnson DC; Joshi RC; Mehta R; Cunnington AR
Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of arterial hypertension after surgery of the abdominal aorta: comparison of captopril and nifedipine administrated sublingually].
Leeman M; Degaute JP
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1267-8. PubMed ID: 8129541
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
[TBL] [Abstract][Full Text] [Related]
10. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
[TBL] [Abstract][Full Text] [Related]
11. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
Domenighetti G
Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
[TBL] [Abstract][Full Text] [Related]
12. Oral slow-release nifedipine in the rapid treatment of severe hypertension in Nigerians.
Arije A; Omotoso AB; Erasmus RT
West Afr J Med; 1994; 13(2):116-20. PubMed ID: 7803325
[TBL] [Abstract][Full Text] [Related]
13. Acute antihypertensive effect of nifedipine by sublingual route in cases with clinically severe systolic hypertension. A study up to 4 h after administration.
Ito H; Arakawa M; Shibasaki T; Hirakawa S; Fukuda T; Yasue T; Kondo Y; Watanabe I; Mori N; Fueki T
Arzneimittelforschung; 1984; 34(5):630-6. PubMed ID: 6380506
[TBL] [Abstract][Full Text] [Related]
14. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of nifedipine in pulmonary hypertension.
Klugmann S; Salvi A; Fioretti P; Camerini F
G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
[TBL] [Abstract][Full Text] [Related]
16. [Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].
Saadjian A; Philip-Joet F; Vestri R; Arnaud A
Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):197-202. PubMed ID: 2735734
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of primary pulmonary arterial hypertension: current status].
Solèr M
Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
[TBL] [Abstract][Full Text] [Related]
18. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
Liu Z; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary pulmonary hypertension with beneficial effect of oral long-acting prostaglandin E1 and nifedipine].
Oida A; Ogawa K; Nagao I; Tsukada K; Yoshimura M
Kokyu To Junkan; 1989 Nov; 37(11):1247-51. PubMed ID: 2602682
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
